These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30833878)

  • 1. Drawing Guideline for
    Kim J
    J Korean Med Sci; 2019 Mar; 34(8):e35. PubMed ID: 30833878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drawing Guideline for JKMS Manuscripts (03): Pyramid Charts.
    Kim J; Lee JS; Jang SJ
    J Korean Med Sci; 2022 May; 37(20):e166. PubMed ID: 35607744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drawing Guideline for
    Kim J; Lee JS; Choi WJ
    J Korean Med Sci; 2023 Jun; 38(22):e190. PubMed ID: 37272564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drawing Guideline for
    Kim J; Lee JS; Kim S
    J Korean Med Sci; 2021 Dec; 36(47):e326. PubMed ID: 34873889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drawing Guidelines for Receiver Operating Characteristic Curve in Preparation of Manuscripts.
    Kim J; Hwang IC
    J Korean Med Sci; 2020 Jun; 35(24):e171. PubMed ID: 32567255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drawing Guideline for
    Kim J; Lee JS; Choi WJ; Yun JY
    J Korean Med Sci; 2024 Apr; 39(16):e149. PubMed ID: 38685891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drawing Guideline for 'Hip and Pelvis': Plot with Error Bar.
    Kim J; Lee JS; Jang SJ
    Hip Pelvis; 2020 Dec; 32(4):161-169. PubMed ID: 33335864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate.
    Morris TP; Jarvis CI; Cragg W; Phillips PPJ; Choodari-Oskooei B; Sydes MR
    BMJ Open; 2019 Sep; 9(9):e030215. PubMed ID: 31575572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey.
    Vervölgyi E; Kromp M; Skipka G; Bender R; Kaiser T
    BMC Med Res Methodol; 2011 Sep; 11():130. PubMed ID: 21936924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaplan-Meier Survival Analysis: Practical Insights for Clinicians.
    Gomes AP; Costa B; Marques R; Nunes V; Coelho C
    Acta Med Port; 2024 Apr; 37(4):280-285. PubMed ID: 38631048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing Time-Varying Effect in Survival Analysis: 5 Complementary Plots to Kaplan-Meier Curve.
    Huang Q; Tian C
    Oxid Med Cell Longev; 2022; 2022():3934901. PubMed ID: 35391933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-sample survival probability curves: A graphical approach for the analysis of time to event data in clinical trials.
    Castro-Pearson S; Le CT; Luo X
    Contemp Clin Trials; 2022 Apr; 115():106707. PubMed ID: 35176502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding survival analysis: actuarial life tables and the Kaplan-Meier plot.
    Barakat A; Mittal A; Ricketts D; Rogers BA
    Br J Hosp Med (Lond); 2019 Nov; 80(11):642-646. PubMed ID: 31707885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail.
    Gong Q; Fang L
    Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kaplan-Meier analysis].
    Tripepi G; Catalano F
    G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysing clinical studies: principles, practice and pitfalls of Kaplan-Meier plots.
    Ludbrook J; Royse AG
    ANZ J Surg; 2008 Mar; 78(3):204-10. PubMed ID: 18269491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIS-based Kaplan-Meier plots--a single source approach for documenting and reusing routine survival information.
    Breil B; Semjonow A; Müller-Tidow C; Fritz F; Dugas M
    BMC Med Inform Decis Mak; 2011 Feb; 11():11. PubMed ID: 21324182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures of follow-up in time-to-event studies: Why provide them and what should they be?
    Betensky RA
    Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials.
    Sherry AD; Msaouel P; Kouzy R; Abi Jaoude J; Lin TA; Taniguchi CM; Fuller CD; Minsky B; Ludmir EB
    Oncologist; 2024 Jul; 29(7):547-550. PubMed ID: 38824414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.